Spearhead Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Spearhead Bio, Inc. - overview
Established
2024
Location
-, -, US
Primary Industry
Biotechnology
About
Based in the US, Spearhead Bio, Inc. , operates as a provider of genome-engineering tools for inserting and replacing DNA sequences in crops. Founded in 2024, Spearhead Bio, Inc. is based in the US and specializes in genome engineering technologies.
This funding will support the advancement of its transposable element platform for precise crop genome editing. Spearhead Bio specializes in advanced genome engineering technologies, specifically through the innovative use of transposable elements to modify plant genomes. Their core offerings enable the precise replacement, insertion, copying, rearrangement, and stacking of large DNA sequences within plants. This process significantly broadens the array of potential crop traits, catering to the needs of seed companies, crop developers, and agricultural biotechnology firms.
The flagship technology, known as TAHITI, combines the pinpoint accuracy of CRISPR with the natural mechanisms of transposable elements, providing a faster, cost-effective solution to crop trait development without introducing foreign DNA. Spearhead Bio's products are aimed at both GMO and non-GMO markets, facilitating agriculture in various geographical regions, including North America, Europe, and parts of Asia. Spearhead Bio operates on a B2B model, focusing on partnerships with seed companies and agricultural innovators for the development of high-value crop traits. Revenue is generated through collaborative agreements, whereby clients engage the company’s genome engineering services for tailored solutions in crop development.
The company conducts transactions through licensing deals and development agreements, allowing partners to utilize proprietary technologies like TAHITI to enhance their crop offerings. These transaction structures may involve upfront fees combined with milestone payments tied to the success of the developed traits. The company plans to advance its transposable element platform for precise crop genome editing, enabling faster trait development than CRISPR alone.
Current Investors
BioGenerator, QRM Capital, Danforth Technology Company
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Farm Support Services, Agribusiness
Website
https://spearheadbio.com/
Verticals
Agtech, Research (Non-Medical)
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Spearhead Bio, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Seed | Completed | Spearhead Bio, Inc. | - | ||||||||
| Unspecified Round | Completed | Spearhead Bio, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.